People · Operator
Named in public records as an officer, director or promoter · active 2009–2015 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SevOne Inc | — | Other Technology | Series D+ | $199.1M | $1.5B | 2009 |
| Collections Marketing Center, Inc. | — | Other Technology | Series A | $24.3M | $210.8M | 2015 |
| Melior Discovery, Inc | — | Pharmaceuticals | Seed | $2.8M | $66.3M | 2009 |
Robert S. Adelson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert S. Adelson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Shanahan | 1 | 8 |
| Bruce Johnson | 1 | 7 |
| J. Benjamin Nye | 1 | 7 |
| Robert Adelson | 1 | 5 |
| Morgan Rodd | 1 | 4 |
| Richard M. Berkeley | 1 | 3 |
| JOHN FARAH | 1 | 3 |
| Benjamin Holzman | 1 | 3 |
| KEVIN DENUCCIO | 1 | 3 |
| Vytas Kisielius | 1 | 2 |
| Nathaniel Lentz | 1 | 2 |
| Ralph Clark | 1 | 2 |
| Vesselin Bakalov | 1 | 2 |
| Ye Zhang | 1 | 2 |
| Jim Melvin | 1 | 2 |
| Tanya Bakalov | 1 | 2 |
| F. Morgan Rodd, Jr. | 1 | 2 |
| Manny Fernandez | 1 | 2 |
| John M. Ryan | 1 | 2 |
| Gregory Bell | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.